ACM
ADCT icon

Aquatic Capital Management’s ADC Therapeutics ADCT Stock Holding History

Aquatic Capital Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.7K Buy
+16,718
New +$65.9K ﹤0.01% 1152
2023
Q3 		– Sell
-2,300
Closed -$5K – 1204
2023
Q2 		$5K Buy
+2,300
New +$5.17K ﹤0.01% 1244
2023
Q1 		– Sell
-700
Closed -$3K – 1207
2022
Q4 		$3K Buy
+700
New +$2.8K ﹤0.01% 1275

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aquatic Capital Management's ADCT Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in ADC Therapeutics (ADCT) in Q1 2026: 16,718 shares worth $62.7K. The stake represents ﹤0.01% of the portfolio and ranks #1152 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in ADCT as recently as Q2 2023.

Aquatic Capital Management first reported a position in ADCT in Q4 2022 and has held it in 3 quarters since. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Aquatic Capital Management held 16,718 shares of ADC Therapeutics worth $62.7K as of Q1 2026.
  • ADC Therapeutics was a new Aquatic Capital Management position in Q1 2026.
  • ADC Therapeutics made up ﹤0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #1152 holding.
  • Aquatic Capital Management first reported a position in ADC Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.